Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,063 | 667 | 97.5% |
| Education | $159.98 | 17 | 1.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $125.00 | 1 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,544 | 101 | $0 (2024) |
| ABBVIE INC. | $1,215 | 75 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $999.14 | 55 | $0 (2024) |
| PFIZER INC. | $921.05 | 71 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $724.92 | 40 | $0 (2024) |
| GlaxoSmithKline, LLC. | $610.34 | 40 | $0 (2024) |
| Lilly USA, LLC | $548.42 | 34 | $0 (2024) |
| Amgen Inc. | $445.89 | 25 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $423.52 | 32 | $0 (2019) |
| Corium, LLC | $307.54 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,930 | 158 | ABBVIE INC. ($407.11) |
| 2023 | $1,873 | 100 | ABBVIE INC. ($482.61) |
| 2022 | $961.81 | 56 | Novo Nordisk Inc ($176.03) |
| 2021 | $296.72 | 18 | AbbVie Inc. ($114.63) |
| 2020 | $432.55 | 26 | Allergan, Inc. ($77.26) |
| 2019 | $1,714 | 111 | Novo Nordisk Inc ($249.09) |
| 2018 | $1,697 | 116 | Novo Nordisk Inc ($216.02) |
| 2017 | $1,443 | 100 | Novo Nordisk Inc ($186.76) |
All Payment Transactions
685 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $34.57 | General |
| Category: Neurology | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Diabetes Care | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $15.94 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 12/02/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $18.61 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: VACCINES | ||||||
| 11/18/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Inflammation | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | ABBVIE INC. | QULIPTA (Drug) | Education | In-kind items and services | $8.45 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/07/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $1.75 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $0.79 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 753 | 3,695 | $311,703 | $114,758 |
| 2022 | 14 | 744 | 3,476 | $286,440 | $100,350 |
| 2021 | 20 | 983 | 3,546 | $317,219 | $138,216 |
| 2020 | 26 | 1,250 | 4,245 | $357,472 | $144,487 |
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 25 | 2,460 | $73,800 | $45,235 | 61.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 288 | 678 | $159,330 | $35,583 | 22.3% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 57 | 142 | $19,880 | $9,711 | 48.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 31 | 31 | $11,935 | $8,726 | 73.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 79 | 79 | $13,430 | $3,254 | 24.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $7,455 | $2,715 | 36.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 30 | 30 | $2,550 | $2,155 | 84.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 26 | 29 | $3,538 | $1,213 | 34.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 33 | 33 | $1,320 | $1,058 | 80.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 31 | 31 | $1,240 | $993.55 | 80.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 14 | $4,270 | $799.92 | 18.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 12 | 13 | $2,015 | $759.72 | 37.7% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 13 | 14 | $2,170 | $709.86 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 15 | $2,325 | $653.62 | 28.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 49 | $2,695 | $575.26 | 21.3% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 28 | 30 | $1,800 | $379.32 | 21.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 25 | 26 | $1,950 | $237.95 | 12.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 27 | 2,340 | $70,200 | $40,403 | 57.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 261 | 562 | $132,070 | $31,293 | 23.7% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 55 | 139 | $29,190 | $9,031 | 30.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 104 | 104 | $17,705 | $4,395 | 24.8% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 26 | 34 | $7,990 | $3,358 | 42.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 42 | 42 | $3,570 | $2,800 | 78.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $5,680 | $2,162 | 38.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 25 | 28 | $4,340 | $1,817 | 41.9% |
About Dr. Joshua Feinberg, DO
Dr. Joshua Feinberg, DO is a Family Medicine healthcare provider based in Broomall, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1326212606.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Feinberg, DO has received a total of $11,348 in payments from pharmaceutical and medical device companies, with $2,930 received in 2024. These payments were reported across 685 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($11,063).
As a Medicare-enrolled provider, Feinberg has provided services to 3,730 Medicare beneficiaries, totaling 14,962 services with total Medicare billing of $497,812. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Broomall, PA
- Active Since 04/17/2008
- Last Updated 05/31/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1326212606
Products in Payments
- VRAYLAR (Drug) $655.11
- JARDIANCE (Drug) $584.66
- Ozempic (Drug) $554.55
- TRELEGY ELLIPTA (Drug) $414.74
- FARXIGA (Drug) $351.98
- UBRELVY (Drug) $337.72
- XARELTO (Drug) $318.67
- TRULICITY (Drug) $259.03
- Saxenda (Drug) $246.44
- ELIQUIS (Drug) $241.71
- Azstarys (Drug) $241.40
- CHANTIX (Drug) $240.98
- QULIPTA (Drug) $214.76
- Rybelsus (Drug) $208.26
- JANUVIA (Drug) $205.49
- Prolia (Biological) $191.75
- BREZTRI (Drug) $189.61
- Vascepa (Drug) $183.19
- PREVNAR 20 (Biological) $154.58
- AIRSUPRA (Drug) $152.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Broomall
Dr. Scott Kurzrok, Do, DO
Family Medicine — Payments: $25,518
Dr. Joseph Labricciosa, Do, DO
Family Medicine — Payments: $23,129
Dr. Donna Delfin, Do, DO
Family Medicine — Payments: $8,705
Dr. Dionne Curran-Chamoun, D.o, D.O
Family Medicine — Payments: $960.68
Dr. Mark Monaco, D.o, D.O
Family Medicine — Payments: $776.12
Phillip Dobson, Md, MD
Family Medicine — Payments: $511.30